What Is Driving Global Artificial Pancreas Device System Market Growth in 2025: The Role of Impact Of Increasing Pancreatic Cancer Prevalence On The Artificial Pancreas Device System Market

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Artificial Pancreas Device System Market Size Growth Forecast: What to Expect by 2025?
The market valuation for artificial pancreas device systems has experienced a swift upward trajectory across the recent timeframe, projected to ascend from $1.81 billion in the year 2024 to $2.06 billion the following year, marking a compound annual growth rate (CAGR) of 13.8%. This surge observed during the historical period is largely attributable to several key factors, including an increasing influx of capital investment, expanding governmental programs supporting clinical investigation, escalating consumer desire for automated solutions in managing blood sugar levels, substantial research and development endeavors undertaken by major industry stakeholders, and a demographic shift towards a larger elderly population.

How Will the Artificial Pancreas Device System Market Size Evolve and Grow by 2029?
Anticipation surrounds the artificial pancreas device system sector, which is projected to experience swift expansion in the approaching years, reaching a valuation of $3.46 billion by 2029, fueled by a compound annual growth rate (CAGR) of 13.8%. This forecasted upturn is primarily underpinned by the rising incidence of diabetes, the increasing frequency of pancreatic cancer diagnoses, the co-occurrence of diabetes and obesity, a burgeoning need for minimally invasive (MI) drug delivery mechanisms, and advancements propelling diabetes management technology forward. Key developments shaping this period ahead encompass technological breakthroughs, intensified research and development efforts, a growing number of authorized products, strategic alliances and cooperative ventures, alongside a rise in teleconsultation services for patient follow-up.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

What Drivers Are Propelling the Growth of Artificial Pancreas Device System Market Forward?
The growing prevalence of pancreatic cancer is anticipated to drive the expansion of the artificial pancreas device system market in the coming years. Pancreatic cancer refers to a malignant growth that begins in the pancreas, a gland situated behind the stomach. Its occurrence is linked to a combination of genetic, lifestyle, environmental, and medical factors, including hereditary pancreatitis caused by genetic mutations that result in chronic pancreatic inflammation. The artificial pancreas device system (APDS) is mainly developed to assist diabetic patients in regulating their blood glucose levels by automatically monitoring sugar levels and delivering the necessary insulin dosage. For instance, in March 2024, Cancer Australia, a government agency, reported that 4,506 new pancreatic cancer cases were diagnosed in 2023, marking an increase from 3,751 cases recorded over the previous five years. Hence, the increasing prevalence of pancreatic cancer is fueling the growth of the artificial pancreas device system market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

Which Emerging Trends Are Transforming the Artificial Pancreas Device System Market in 2025?
Leading entities within the artificial pancreas device system market are focused on innovating automated insulin delivery mechanisms intended to significantly improve diabetes care through continuous tracking of blood sugar and the corresponding, requisite insulin dosage release. The objective of these automated insulin delivery solutions is to mimic the operations of a normally functioning pancreas, thereby alleviating the daily requirement for continuous glucose checks and hands-on insulin injections for diabetic patients. A pertinent example is demonstrated by Beta Bionics, an American manufacturer of medical technology, which secured its 510(k) authorization from the FDA in May 2023 for its bionic pancreas utilizing only insulin, known as the iLet system. This particular artificial pancreas apparatus functions by automatically ascertaining and administering the precise insulin units needed to maintain stable blood sugar readings. Operating as a closed-loop circuit, the device modifies insulin administration autonomously according to the glucose readings obtained from an integrated continuous glucose monitoring device (CGM), necessitating only the patient's body weight and an approximation of the forthcoming meal size to manage insulin delivery automatically.

What Are the Key Segments in the Artificial Pancreas Device System Market?
The artificial pancreas device systemmarket covered in this report is segmented -

1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid
3) By End-User: Hospitals; Medical Centers; Other End-Users

Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend; Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems; Insulin Delivery Systems with Range Control; Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems; Insulin Pumps with Targeted Glucose Control; Automated Glucose Regulation Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp

Who Are the Key Players Shaping the Artificial Pancreas Device System Market's Competitive Landscape?
Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

What Geographic Markets Are Powering Growth in the Artificial Pancreas Device System Market?
North America was the largest region in the artificial pancreas device system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.